Marathon Capital Management Myriad Genetics Inc Transaction History

Marathon Capital Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$22.08 - $47.08 $1.75 Million - $3.74 Million	-79,460 Closed	0 $0
Q2 2019 Jul 25, 2019	BUY	$22.67 - $35.0 $1.8 Million - $2.78 Million	79,460 New	79,460 $2.21 Million
Q4 2018 Feb 07, 2019	SELL	$27.23 - $45.56 $136,150 - $227,800	-5,000 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$37.57 - $50.34 $187,850 - $251,700	5,000 New	5,000 $230,000

227

92M

297K

20.7K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.17B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Marathon Capital Management, based on Form 13F filings with the SEC.

Stay updated on Marathon Capital Management with notifications on news.